martes, 21 de abril de 2026

Locally Advanced Rectal Cancer Responds to HER2 Therapy Will Pass April 21, 2026 +++ +++

Locally Advanced Rectal Cancer Responds to HER2 Therapy Will Pass https://www.medscape.com/viewarticle/locally-advanced-rectal-cancer-responds-her2-therapy-2026a1000chn April 21, 2026 American Association for Cancer Research (AACR) Annual Meeting 2026 https://www.medscape.com/c25/p14/american-association-cancer-research-aacr-annual-meeting-2026a10009yj NICE Backs New Oral Second-Line Option for CLL Dr Sheena Meredith https://www.medscape.com/viewarticle/nice-backs-new-oral-option-second-line-cll-2026a1000chv Medscape UK April 21, 2026 Can Oncotype DX Predict Recurrence Risk in Older Patients With Breast Cancer? Edited by Victoria Stern https://www.medscape.com/viewarticle/can-oncotype-dx-predict-recurrence-risk-older-patients-2026a1000cfd April 21, 2026 AI Holds Promise in Dermatology, Issues Remain to be Addressed Damian McNamara, MA https://www.medscape.com/viewarticle/ai-holds-promise-dermatology-issues-remain-be-addressed-2026a1000cik April 21, 2026 Should Aspirin Be Reconsidered for Colon Cancer Prevention? Cristina Ferrario https://www.medscape.com/viewarticle/should-aspirin-be-reconsidered-colon-cancer-prevention-2026a1000cge April 21, 2026

No hay comentarios:

Publicar un comentario